Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

Author(s):
Ford, J.; Lawson, M.; Fowler, D.; Maruyama, N.; Mito, S.; Tomiyasu, K.; Kinoshita, S.; Suzuki, C.; Kawaguchi, A.; Round, P.; Boyce, M.; Warrington, S.; Weber, W.; Deventer, S. van; Kastelein, J.J.P.
Published
2014
Publication type
Article / Letter to editor
apolipoproteinscardiovascular diseasescholesterolcoronary diseasehypercholesterolaemia
Date issued
2014-09-30
Language
English
Is part of
British Journal of Clinical Pharmacology (2014), Vol. 78, no. 3, p. 498-508
hdl
1887/117373
doi
10.1111/bcp.12380